Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Low-dose hydrocortisone treatment is widely accepted therapy for the treatment of vasopressor-dependent septic shock. The question of whether corticosteroids should be given to septic shock patients by continuous or by bolus infusion is still unanswered. Hydrocortisone induces hyperglycemia and it is possible that continuous hydrocortisone infusion would reduce the fluctuations in blood glucose levels and that tight blood glucose control could be better achieved with this approach. METHODS: In this prospective randomized study, we compared the blood glucose profiles, insulin requirements, amount of nursing workload needed, and shock reversal in 48 septic shock patients who received hydrocortisone treatment either by bolus or by continuous infusion with equivalent dose (200 mg/day). Duration of hydrocortisone treatment was five days. RESULTS: The mean blood glucose levels were similar in the two groups, but the number of hyperglycemic episodes was significantly higher in those patients who received bolus therapy (15.7 +/- 8.5 versus 10.5 +/- 8.6 episodes per patient, p = 0.039). Also, more changes in insulin infusion rate were needed to maintain strict normoglycemia in the bolus group (4.7 +/- 2.2 versus 3.4 +/- 1.9 adjustments per patient per day, p = 0.038). Hypoglycemic episodes were rare in both groups. No difference was seen in shock reversal. CONCLUSION: Strict normoglycemia is more easily achieved if the hydrocortisone therapy is given to septic shock patients by continuous infusion. This approach also reduces nursing workload needed to maintain tight blood glucose control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while supraphysiologic peaks might come with adverse side effects, as previously shown in the context of sepsis with an increased rate of hyperglycemic episodes (22).”
From Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery (2020) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“APACHE (Acute Physiology and Chronic Health Evaluation) II score [15] and SAPS (Simplified Acute Physiology Score) II [16] were calculated and the severity of organ dysfunction was assessed using SOFA (Sepsis-related Organ Failure Assessment) score [17] at the time of ICU admission.”
MethodBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773 · cited 1×
“APACHE (Acute Physiology and Chronic Health Evaluation) II score [15] and SAPS (Simplified Acute Physiology Score) II [16] were calculated and the severity of organ dysfunction was assessed using SOFA (Sepsis-related Organ Failure Assessment) score [17] at the time of ICU admission.”
MethodAPACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Cited by
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Annane, D., Bellissant, E., Bollaert, P.-E., Briegel, J., Confalonieri, M., De Gaudio, R., Keh, D., Kupfer, Y., Oppert, M., & Meduri, G. U. (2009) · JAMA · doi:10.1001/jama.2009.815 · Cited by 561
“One randomized controlled trial suggested that continuous hydrocortisone infusion, compared with bolus administration, might result in fewer episodes of hyperglycemia.(60) The recent update of the Surviving Sepsis Campaign suggested that intravenous hydrocortisone should be given only to adult septic shock patients af…”
Critical Illness-Related Corticosteroid Insufficiency
Marik, P. E. (2009) · Chest · doi:10.1378/chest.08-1149 · Cited by 299
Keh, D., Trips, E., Marx, G., Wirtz, S. P., Abduljawwad, E., Bercker, S., Bogatsch, H., Briegel, J., Engel, C., Gerlach, H., et al. (2016) · JAMA · doi:10.1001/jama.2016.14799 · Cited by 277
“Hospital 25 (16-40) 26 (16-46) 26 (16-43) .”
Activation and Regulation of Systemic Inflammation in ARDS
Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E., & Sinclair, S. E. (2009) · Chest · doi:10.1378/chest.08-2408 · Cited by 260
Corticosteroids for treating sepsis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub3 · Cited by 210
Corticosteroids for treating sepsis in children and adults
Annane, D., Bellissant, É., Bollaert, P. E., Briegel, J., Keh, D., Kupfer, Y. Y., Pirracchio, R., & Rochwerg, B. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub4 · Cited by 200
Corticosteroids in Acute Lung Injury: The Dilemma Continues
Mokra, D., Mikolka, P., Kosutova, P., & Mokry, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194765 · Cited by 166
“For sepsis, hydrocortisone was the most commonly used CS agent, at a dose of 200–300 mg/day given as an infusion (with a bolus of 50–100 mg given before infusion) or as boluses every 6 h, typically for 7–14 days [110,130].”
MethodCorticosteroid therapy for sepsis: a clinical practice guideline
Lamontagne, F., Rochwerg, B., Lytvyn, L., Guyatt, G. H., Møller, M. H., Annane, D., Kho, M. E., Adhikari, N. K. J., Machado, F., Vandvik, P. O., et al. (2018) · BMJ · doi:10.1136/bmj.k3284 · Cited by 125
Corticosteroids for severe sepsis: an evidence-based guide for physicians
Annane, D. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-7 · Cited by 139
Blood glucose control in patients with severe sepsis and septic shock
Hirasawa, H., Oda, S., & Nakamura, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4132 · Cited by 110
“administration may create some difficulties in glycemic control in septic patients [ 43 ]”
BackgroundCorticosteroids for treating severe sepsis and septic shock
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub2 · Cited by 109
Moran, J. L., Graham, P. L., Rockliff, S., & Bersten, A. D. (2010) · Critical Care · doi:10.1186/cc9182 · Cited by 110
“Loisa and colleagues [86] 2007 Two hydrocortisone arms; no concurrent placebo group”
BackgroundPrete, A., Taylor, A. E., Bancos, I., Smith, D. J., Foster, M. A., Kohler, S., Fazal-Sanderson, V., Komninos, J., O’Neil, D. M., Vassiliadi, D. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa133 · Cited by 96
de Grooth, H.-J., Postema, J., Loer, S. A., Parienti, J.-J., Oudemans-van Straaten, H. M., & Girbes, A. R. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5134-8 · Cited by 92
Gibbison, B., Angelini, G. D., & Lightman, S. L. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet077 · Cited by 87
The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update
Annane, D. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00070 · Cited by 83
“A total of eight trials (n = 1132 patients) (71) reported a dramatic reduction in the number and degree of severity of failing organs, with a mean reduction in the SOFA score – a measure of organ dysfunction (79) – of −1.”
BackgroundMeduri, G. U., & Chrousos, G. P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00161 · Cited by 84
“an intermittent bolus was associated with more rapid resolution of shock (310), and fewer hyperglycemic episodes (311, 312).”
BackgroundGlucocorticoid Treatment in Acute Lung Injury and Acute Respiratory Distress Syndrome
Marik, P. E., Meduri, G. U., Rocco, P. R. M., & Annane, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.05.007 · Cited by 67
Corticosteroids for Treating Sepsis in Adult Patients: A Systematic Review and Meta-Analysis
Liang, H., Song, H., Zhai, R., Song, G., Li, H., Ding, X., Kan, Q., & Sun, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.709155 · Cited by 62
“(43) RCT S 07/2005–04/2006 48/NA NA NA Septic shock Sepsis2 NA Hydrocortison 50 mg/6 h for Confalonieri et al.”
BackgroundThe role of glucocorticoids as adjunctive treatment for sepsis in the modern era
Marik, P. E. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30265-0 · Cited by 50
Wang, C., Sun, J., Zheng, J., Guo, L., Ma, H., Zhang, Y., Zhang, F., & Li, E. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000050 · Cited by 54
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Kalil, A. C., & Sun, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002291 · Cited by 40
Optimal Glucose Management in the Perioperative Period
Evans, C. H., Lee, J., & Ruhlman, M. K. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.11.003 · Cited by 43
“Incidentally, steroid boluses and drips are used as an adjunct to pressors during septic shock.(62) However, steroids can also induce hyperglycemia and insulin intolerance.”
BackgroundTilouche, N., Jaoued, O., Ali, H. B. S., Gharbi, R., Hassen, M. F., & Elatrous, S. (2019) · Shock · doi:10.1097/shk.0000000000001316 · Cited by 33
“(11) excluded diabetic patients which explains an easier control of glycaemia.”
BackgroundInfluentialDrug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
“The impact of steroids on glycemic control can be minimized by administering the steroid as a continuous infusion instead of bolus dosing (173).”
BackgroundPetersen, M. W., Meyhoff, T. S., Helleberg, M., Kjær, M. N., Granholm, A., Hjortsø, C. J. S., Jensen, T. S., Møller, M. H., Hjortrup, P. B., Wetterslev, M., et al. (2020) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13673 · Cited by 30
Verhoeven, J. J., den Brinker, M., Hokken-Koelega, A., Hazelzet, J. A., & Joosten, K. F. M. (2011) · Critical Care · doi:10.1186/cc10006 · Cited by 29
“Hyperglycemic episodes were more common in adult septic shock patients who received hydrocortisone in bolus therapy as compared with those who received a continuous infusion with an equivalent dose [34].”
BackgroundCorticosteroids for treating sepsis in children and adults
Annane, D., Briegel, J., Granton, D., Bellissant, É., Bollaert, P., Keh, D., Kupfer, Y. Y., Pirracchio, R., & Rochwerg, B. N. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub5 · Cited by 40
Meduri, G. U., Bell, W., Sinclair, S. E., & Annane, D. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.04.023 · Cited by 25
“Glucocorticoid treatment should be administered as a continuous infusion (while the patient is in ICU) to minimize glycemic variations [85,86].”
BackgroundMethodThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome
Meduri, G. U., Rocco, P. R. M., Annane, D., & Sinclair, S. E. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.2 · Cited by 20
Recent Data about the Use of Corticosteroids in Sepsis—Review of Recent Literature
Lazăr, A. E. (2024) · Biomedicines · doi:10.3390/biomedicines12050984 · Cited by 20
“The treatment group that received the combination therapy showed a remarkable reduction in mortality compared to the control group (8.5% vs. 40.4%).”
ResultInfluentialHydrocortisone in Vasodilatory Shock
Venkatesh, B., & Cohen, J. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.005 · Cited by 20
Briegel, J., Vogeser, M., Keh, D., & Marik, P. E. (2009) · Der Anaesthesist · doi:10.1007/s00101-009-1515-2 · Cited by 18
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review
Japiassú, A. M., Salluh, J. I., Bozza, P. T., Bozza, F. A., & Castro-Faria-Neto, H. C. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000400001 · Cited by 22
“…explanation for these contrasting observations is that the mode of hydrocortisone administration could have an impact on glycemic control, as shown with bolus injections and a higher fluctuation in blood glucose levels would impact the outcome (Loisa et al. 2007, Weber-Carstens et al. 2007).”
BackgroundVenkatesh, B., & Cohen, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003834 · Cited by 15
“org December 2019 • Volume 47 • Number 12 and fewer adverse metabolic effects (8) and in accord with current clinical practice recommendations for septic shock (8, 9).”
Backgroundvan Hooijdonk, R. T. M., Binnekade, J. M., Bos, L. D. J., Horn, J., Juffermans, N. P., Abu–Hanna, A., & Schultz, M. J. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0077-5 · Cited by 16
“Bolus infusion of hydrocortisone, however, could induce short episodes of hyperglycemia frequently requiring temporary adjustments of the insulin infusion rate in critically ill patients [2, 3].”
BackgroundResultInfluentialHoang, H., Wang, S., Islam, S., Hanna, A. F., Axelrad, A., & BRATHWAITE, C. E. M. (2017) · PubMed Central · Cited by 14
Zhou, X., Hu, C., Yao, L., Fan, Z., Sun, L., Wang, Y., & Xu, Z. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.09.013 · Cited by 13
Should we abandon corticosteroids during septic shock? No
Groeneveld, A. B. J., Molenaar, N., & Beishuizen, B. (2008) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328306a01d · Cited by 12
Corticosteroids for Septic Shock: Another Chapter in the Saga
Yerke, J. R., Strnad, K., & Bauer, S. R. (2019) · Hospital Pharmacy · doi:10.1177/0018578719829416 · Cited by 13
“However, comparisons of a bolus dosing strategy with a continuous infusion strategy are not robust in regard to clinical outcomes, and neither major trial that observed mortality benefit utilized a continuous infusion strategy.(13,16,25,26) If a continuous infusion administration strategy is used, it should be initiat…”
BackgroundLin, L., Gu, H.-Y., Luo, J., Wang, L., Zhang, C., Niu, Y., & Zuo, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01101 · Cited by 14
Bolus or continuous hydrocortisone--that is the question.
Weber‐Carstens, S., & Keh, D. (2007) · Critical Care · doi:10.1186/cc5669 · Cited by 12
“the one conducted by Loisa and coworkers [1].”
BackgroundMethodInfluentialVogelzang, M., Hoekstra, M., Drost, J. T., Janse, M., van der Horst, I. C. C., Boonstra, P. W., Zijlstra, F., Loef, B. G., & Nijsten, M. W. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-39 · Cited by 13
“For other patient categories, effects on glucose control have recently been shown for hydrocortisone in patients with septic shock [22], or for dexamethasone against nausea in abdominal surgery patients [23].”
The steady motion of microbubbles in bifurcating airways: Role of shear-thinning and surface tension
Munir, B., & Xu, Y. (2021) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2021.103675 · Cited by 10
Mitwally, H., Saad, M. O., Mahmoud, S., & Mohamed, A. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23501 · Cited by 9
“13 Despite being statistically significant, the results were not clinically significant, as the difference in mean blood glucose was only 0.2 mmol/L.”
InfluentialFoushee, J. A., Meredith, P., Fox, L. M., & Wilder, A. G. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa118 · Cited by 9
Life-threatening ANCA-positive vasculitis associated with rickettsial infection: Figure 1
Nickerson, A., & Marik, P. E. (2012) · BMJ Case Reports · doi:10.1136/bcr.03.2012.5993 · Cited by 9
“A number of studies have demonstrated better glycaemic control (fewer glucose fluctuations) when patients receive glucocorticoids as a continuous infusion.(14) 15 A recent randomised controlled trial in trauma patients demonstrated a lower incidence of hospital acquired pneumonia and Figure 1 Skin biopsy demonstrating…”
Adjunctive Corticosteroid Treatment in Septic Shock
Cohen, J., & Venkatesh, B. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002604 · Cited by 11
Salton, F., Confalonieri, P., Meduri, G. U., Mondini, L., Trotta, L., Barbieri, M., Bozzi, C., Torregiani, C., Lerda, S., Bellan, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070924 · Cited by 8
“In various works on pharmacokinetics, severe pneumonia septic shock, it emerged that when compared to intermittent boluses, infusion allowed to achieve: (i) a lower variability in plasma concentration [50]; (ii) a better lung penetration; (iii) a steady, nonfluctuating exposure; (iv) higher response levels throughout…”
BackgroundRam, G. K., Shekhar, S., Singh, R. B., Anand, R., De, R. R., & Kumar, N. (2022) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_115_22 · Cited by 8
Glucocorticoid therapy for sepsis in the AI era: a survey on current and future approaches
Liang, C., Pan, S., Wu, W., Chen, F., Zhang, C., Zhou, C., Gao, Y., Ruan, X., Quan, S., Zhao, Q., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.020 · Cited by 7
“Preliminary evidence suggests intravenous continuous infusion might be superior to push administration, as highlighted by Loisa [39] and Weber-Carstens [40] in 2007.”
BackgroundLi, Y., Wang, Y., Guo, J., & Zhang, D. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.05.001 · Cited by 6
Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles
Meduri, G. U., Confalonieri, M., Chaudhuri, D., Rochwerg, B. N., & Meibohm, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00019-6 · Cited by 11
Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia
Ugajin, M., Yamaki, K., Kobayashi, T., Yagi, T., & Hirasawa, N. (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s49275 · Cited by 6
Adjunctive therapies in severe sepsis and septic shock: Current place of steroids
Keh, D., Weber‐Carstens, S., & Ahlers, O. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0058-z · Cited by 6
Tyagi, A., Salhotra, R., Sharahudeen, A., Rautela, R. S., & Kemprai, R. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24793 · Cited by 5
“17 Previous studies have used hydrocortisone in a dose of 200– 300 mg. 6,10 When used in a dose of 300 mg/day, no additional benefit could be demonstrated.”
MethodThe Role of SR-BI in sepsis: leveraging mechanistic insights to advance precision steroid therapy
Guo, L., Wang, Q., & Li, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643395 · Cited by 4
Steroid Therapy for Patients with Septic Shock: A Multicenter Observational Study Conducted in Japan
Murata, M., Shimizu, S., Yamamoto, R., Kamitani, T., Yamazaki, H., Ogawa, Y., Fukuhara, S., Yasuda, H., Yamamoto, Y., & on behalf of the AMOR-VENUS study group (2024) · Internal Medicine · doi:10.2169/internalmedicine.1511-22 · Cited by 5
“Several randomized controlled trials (RCTs) have investigated whether the intermittent or continuous infusion of steroids improves the patient prognosis (13-17).”
Complications Associated with Glucocorticoids Treatment in Critically Ill Patients
Confalonieri, P., Reccardini, N., Kette, S., & Salton, F. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2661-5208 · Cited by 4
Weiß, M., Kron, M., Hay, B., Taenzer, M., Radermacher, P., & Georgieff, M. (2011) · Patient Safety in Surgery · doi:10.1186/1754-9493-5-5 · Cited by 4
“In this context, the following variables have been reported to be associated with increased risk for hypoglycemia or hyperglycemia: age [12,13], sex [12], type of surgery; severity of disease [14] and severe systemic inflammatory response syndrome (SIRS)/sepsis [15,16]; kidney [14,17], liver [17] and organ dysfunction…”
BackgroundHydrocortisone Continuous Infusion Versus Bolus Dose on Glycemic Control in Critically Ill Subjects
Coles, L. L., Forehand, C. C., & Quidley, A. M. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019850937 · Cited by 3
“Loisa et al conducted a prospective, randomized study of 48 subjects to assess glucose profiles in patients with septic shock who received either 200 mg/d CI hydrocortisone (n 1⁄4 22) or a 50 mg bolus every 6 hours for 5 days.(13) The primary end point was difference in mean BG with a target goal of 72 to 126 mg/dL.”
MethodMahmoudi, P. S., Sadeghi, F., Saberian, M., Khalili, H., & Shafaati, M. (2026) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00335-x · Cited by 3
“Glycemic variability, measured as the coefficient of variation, was analyzed in six studies [27, 39, 42–45].”
InfluentialMeduri, G. U., & Chrousos, G. P. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/paendo.1.2020.10 · Cited by 3
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_39 · Cited by 3
Steroids and Vasopressin in Septic Shock—Brother and Sister or Just Distant Cousins?*
Asfar, P., Tuckermann, J. P., & Radermacher, P. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000262 · Cited by 3
Do Corticosteroids Improve Mortality or Shock Reversal in Patients With Septic Shock?
Long, B., & April, M. D. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.05.025 · Cited by 3
Kortikosteroide bei schwerer Sepsis und septischem Schock
Keh, D., Briegel, J., Niederberger, S., Krebs, M., & Ahlers, O. (2009) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-009-0112-6 · Cited by 2
Adrenal Insufficiency and CIRCI
Marik, P. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5923-2_40 · Cited by 1
“7 Since blood glucose variability has been demonstrated to have prognostic implications, 8, 9 a continuous infusion of a glucocorticoid may have additional benefits.”
BackgroundGréve, F. V. S., van der Sluijs, K. F., Juffermans, N. P., Winters, T., Rebers, S. P. H., SPVerheul, K., Molenkamp, R., de Man, A., Spronk, P. E., de Jong, M. D., et al. (2014) · Critical Care · doi:10.1186/cc13531 · Cited by 2
Sepsis-Update: evidenzbasierte Therapie
Märtin, L., Bickenbach, J., & Marx, G. (2019) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-0625-5521 · Cited by 1
“[46] Loisa P, Parviainen I, Tenhunen J et al.”
BackgroundArai, T., Mori, Y., Yoshizaki, S., Andõ, R., Natori, S., Morishita, S., Otani, M., 沼田, 篤., & Osanai, H. (2021) · Oxford Medical Case Reports · doi:10.1093/omcr/omab109 · Cited by 1
“Various effects of glucocorticoids, including immune-modulating properties through interaction with NF-κB and elevation of blood glucose levels by stimulating glycogenesis in the liver and peripheral tissues, are favorable against septic shock [7].”
BackgroundA szérumkortizolszintek és a sokszervi működészavar összefüggése oxigénhiányt átélt újszülöttekben
Kerekes, R., Dobi, M., Jermendy, Á., Szabó, M., & Kovács, K. D. (2025) · Orvosi Hetilap · doi:10.1556/650.2025.33317 · Cited by 1
The Stress Response, Stress Hyperglycemia and Stress Hyperlactemia
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_13 · Cited by 1
Glucocorticoids in the treatment of acute respiratory distress syndrome
Roche‐Campo, F., Aguirre-Bermeo, H., & Mancebo, J. (2011) · Réanimation · doi:10.1007/s13546-011-0316-1 · Cited by 1
“In patients with septic shock, premature discontinuation of GCs may be associated with a spike in markers of inflammation and a worsening of hemodynamic parameters [71]; • Continuous perfusion rather than intermittent bolus administration may reduce glycemia variability and improve its control [72].”
BackgroundMiranda, M. P. F. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2009.tde-11012010-150622
Impact of corticosteroid administration in septic shock on glycemic variability
Mirea, L., Ungureanu, R., Pavelescu, D., Grintescu, I., Dumitrache, C., Mirea, D., & Grințescu, I. M. (2014) · Critical Care · doi:10.1186/cc13635
Endocrine Issues in Neurocritical Care
Greenberg, S. B., Tokarczyk, A. J., Zahed, C., & Coursin, D. B. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5226-2_15
Corticotherapy in severe sepsis and septic shock
Carolina, A., Porto, P. M. D. M., Cláudia, A., Gianini, C., Sant, B., de Paiva, B. M. G., de Paiva, G., Silva, E. S., Manin, M. G., & PENNA, H. A. D. (2011)
(2012) · Informa Healthcare eBooks · doi:10.3109/9781841849232.007
THE EFFECT OF LOW DOSE HYDROCROTISONE ON DURATION OF VASOPRESSOR THERAPY IN SEPTIC SHOCK
Deep, G., Verma, K. B., Ghosh, S., Chandana, C., & Goel, S. K. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/694
Behçet’s Disease: Pulmonary Aneurysm Resolution with Oral Therapy and HLA B72 Allele Association
Botura, C. D. A., Bersani‐Amado, L. E., Zacarias-Júnior, A. R., Borelli, S. D., Stecca, N. G. G., da Rocha, B. A., Cuman, R. K. N., & Bersani‐Amado, C. A. (2018) · Clinical Medicine & Research · doi:10.3121/cmr.2017.1386
Cihoric, M., Kehlet, H., Lauritsen, M. L., Højlund, J., Kanstrup, K., & Foss, N. B. (2022) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14040
Keh, D. (2015) · Springer eBooks · doi:10.1007/978-3-662-45148-9_15
(2008) · Nursing (Ed española) · doi:10.1016/s0212-5382(08)71276-7
Venkatesh, B., & Cohen, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004014
(2012) · Informa Healthcare eBooks · doi:10.3109/9781842145883.007
Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be
Todi, S. K. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24798
Emami, E., Molaei, E., Ghazi, S. F., Sohrabi, M., & Khalili, H. (2025) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-025-00571-0
“First, early HC administration in septic shock has been shown to provide sustained hemodynamic benefits and accelerate shock resolution [18, 19].”
When and How Much? Steroids in Sepsis
CROSLEY, E. L., Yang, P., & Esper, A. M. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.10.004
Khan, A. S., Ahmad, F., Khan, A. A., Khan, Z., Ahmed, T., Wazir, A., Khan, H. U., Ali, A., Khan, H., Khan, A. Y., et al. (2026) · Medical Principles and Practice · doi:10.1159/000551004
Influence of Hydrocortisone on Blood Profile, Total Protein, And Glucose in Female Rabbits
Ali, W. D. A. (2025) · Medicra (Journal of Medical Laboratory Science/Technology) · doi:10.21070/medicra.v8i1.1783
“These results confirm our findings in Table 2 Loisa et al., (2007).”
Jia, Z., Zhao, X., Liu, X., & 李小丽 (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1962609
“Administration mode may also modify exposure patterns: a small randomized study found similar mean glucose concentrations with continuous and intermittent hydrocortisone, but more hyperglycemic excursions and insulin adjustments with bolus dosing (Loisa et al., 2007).”
Metadata
- Authors
- Loisa, P., Parviainen, I., Tenhunen, J., Hovilehto, S., & Ruokonen, E.
- Affiliations
- Päijät-Hämeen Keskussairaala (FI)
- Kuopio University Hospital (FI)
- Tampere University Hospital (FI)
- South Karelia Central Hospital (FI)
- Corresponding author
- Loisa, Pekka
- ORCID
- Tenhunen, Jyrki
- Venue
- Critical Care
- Published
- 2007-02-16
- Volume
- 11
- Issue
- 1
- Pages
- R21-R21
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2151907
- OpenAlex
- W1954574580
- Cited by
- 95
- References
- 27
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 11 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tays
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- septic shock, cortisol, continuous infusion, bolus infusion, glycemic control, hyperglycemia, insulin requirement, nursing workload, corticosteroid therapy
- MeSH terms
- Anti-Inflammatory Agents, Blood Glucose, Humans, Hydrocortisone, Hyperglycemia, Infusions, Intravenous, Injections, Intravenous, Middle Aged, Prospective Studies, Shock, Septic, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.